BioMed Central | Articles which cite: PTPN22 polymorphism and anti-cyclic citrullinated peptide antibodies in combination strongly predicts future onset of rheumatoid arthritis and has a specificity of 100% for the disease.

Log on / register
Feedback | Support | My details

home journals A-Z subject areas advanced search authors reviewers libraries about my BioMed Central

PTPN22 polymorphism and anti-cyclic citrullinated peptide antibodies in combination strongly predicts future onset of rheumatoid arthritis and has a specificity of 100% for the disease.
Johansson M, Arlestig L, Hallmans G, Rantapää-Dahlqvist S
Arthritis Res Ther 2006, 8:R19
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]

printer friendly

to [Help]

PubMed Central articles that cite the above article:

1.	The MHC2TA -168A>G gene polymorphism is not associated with rheumatoid arthritis in Austrian patients. Yazdani-Biuki B, Brickmann K, Wohlfahrt K, Mueller T, März W, Renner W, Gutjahr M, Langsenlehner U, Krippl P, Wascher TC, Paulweber B, Graninger W, Brezinschek HP Arthritis Res Ther 2006, 8:R97 [PubMed Central] [PubMed] [Related articles]
2.	Linkage proof for PTPN22, a rheumatoid arthritis susceptibility gene and a human autoimmunity gene. Michou L, Lasbleiz S, Rat AC, Migliorini P, Balsa A, Westhovens R, Barrera P, Alves H, Pierlot C, Glikmans E, Garnier S, Dausset J, Vaz C, Fernandes M, Petit-Teixeira E, Lemaire I, Pascual-Salcedo D, Bombardieri S, Dequeker J, Radstake TR, Van Riel P, van de Putte L, Lopes-Vaz A, Prum B, Bardin T, Dieudé P, Cornélis F, European Consortium on Rheumatoid Arthritis Families Proc Natl Acad Sci U S A 2007 Jan 30, 104:1649-54 [PubMed Central] [PubMed] [Related articles]
3.	The PTPN22 1858C/T polymorphism is associated with anti-cyclic citrullinated peptide antibody-positive early rheumatoid arthritis in northern Sweden. Kokkonen H, Johansson M, Innala L, Jidell E, Rantapää-Dahlqvist S Arthritis Res Ther 2007, 9:R56 [PubMed Central] [PubMed] [Related articles]
4.	Arthritis induced by posttranslationally modified (citrullinated) fibrinogen in DR4-IE transgenic mice. Hill JA, Bell DA, Brintnell W, Yue D, Wehrli B, Jevnikar AM, Lee DM, Hueber W, Robinson WH, Cairns E J Exp Med 2008 Apr 14, 205:967-79 [PubMed Central] [PubMed] [Related articles]

This article is also cited by 1 article in BioMed Central

You can also check ISI Web of Science for additional citations (subscription required)

printer friendly

to [Help]

Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us